Engineers Gate Manager LP acquired a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 20,291 shares of the company’s stock, valued at approximately $1,664,000.
Several other large investors have also made changes to their positions in HSIC. YorkBridge Wealth Partners LLC grew its position in Henry Schein by 5.2% in the 2nd quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after purchasing an additional 28 shares during the last quarter. Sun Life Financial INC grew its position in Henry Schein by 8,185.7% in the 2nd quarter. Sun Life Financial INC now owns 580 shares of the company’s stock worth $106,000 after purchasing an additional 573 shares during the last quarter. Acrospire Investment Management LLC grew its position in Henry Schein by 150.0% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,000 shares of the company’s stock worth $183,000 after purchasing an additional 600 shares during the last quarter. HM Payson & Co. bought a new position in Henry Schein in the 2nd quarter worth about $204,000. Finally, Great Lakes Advisors LLC bought a new position in Henry Schein in the 2nd quarter worth about $205,000. 91.75% of the stock is owned by institutional investors and hedge funds.
In related news, Director Barry J. Alperin sold 5,796 shares of the stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $70.76, for a total transaction of $410,124.96. Following the completion of the sale, the director now directly owns 48,172 shares of the company’s stock, valued at $3,408,650.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.19% of the stock is owned by corporate insiders.
Shares of Henry Schein, Inc. (HSIC) opened at $67.90 on Friday. The firm has a market cap of $10,660.00, a P/E ratio of 18.96, a PEG ratio of 1.90 and a beta of 0.99. Henry Schein, Inc. has a one year low of $65.28 and a one year high of $93.50. The company has a quick ratio of 0.86, a current ratio of 1.55 and a debt-to-equity ratio of 0.30.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Monday, November 6th. The company reported $0.87 earnings per share for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.03). The company had revenue of $3.16 billion during the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The company’s revenue was up 10.3% on a year-over-year basis. During the same period in the prior year, the company posted $0.84 earnings per share. research analysts anticipate that Henry Schein, Inc. will post 3.6 earnings per share for the current year.
Henry Schein announced that its board has approved a stock repurchase plan on Monday, September 18th that allows the company to buyback $400.00 million in shares. This buyback authorization allows the company to purchase up to 6.3% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s board of directors believes its shares are undervalued.
ILLEGAL ACTIVITY WARNING: This article was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this article on another publication, it was illegally copied and republished in violation of international copyright and trademark law. The original version of this article can be accessed at https://sportsperspectives.com/2017/12/10/20291-shares-in-henry-schein-inc-hsic-purchased-by-engineers-gate-manager-lp.html.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.